NASDAQ:CGON | Free Cash Flow | CG Oncology, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2023-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$56.94M$304,000.00-$57.25M
2025-12-31-$36.22M$7,000.00-$36.22M
2025-03-31-$29.28M$16,000.00-$29.29M
2024-12-31-$20.66M$209,000.00-$20.87M
2024-03-31-$26.01M$12,000.00-$26.02M
2023-12-31-$14.65M
2023-03-31-$7.99M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$132.35M$134,000.00-$132.48M
2024-12-31-$78.71M$234,000.00-$78.95M
2023-12-31-$45.68M